Yes, this has certainly be well explored and discussed, should not have affected the future unduly nor what ever is going on behind the scenes that WP is currently negotiating.
Not sure what impact it may have had 3 years ago, I am sure the medical field do expect that there will inevitably be adverse reactions from the best of medical advances/IP, Eg; as per Medtronics (?) going back to the drawing board.
Focus absolutely now on moving forward and the necessary funding to ‘fast track’ its current IP and then those in the pipeline.
I really do hope that we will not be disappointed on resume of trading, plenty to discuss then I am sure.
New Report, page-8
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.00 |
Change
0.000(0.00%) |
Mkt cap ! $253.6M | |||
| Open | High | Low | Value | Volume |
| $11.88 | $12.00 | $11.50 | $261.8K | 22.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 156 | $11.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.00 | 6045 | 3 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |